Unexpected <i>in crystallo</i> reactivity of the potential drug bis(maltolato)oxidovanadium(<scp>iv</scp>) with lysozyme-Reference-Cited by-同舟云学术

Unexpected in crystallo reactivity of the potential drug bis(maltolato)oxidovanadium(iv) with lysozyme

Published:2024 Issue: Volume: Page:
ISSN:2052-1553
Container-title:Inorganic Chemistry Frontiers
language:en
Short-container-title:Inorg. Chem. Front.

Author:

Paolillo Maddalena¹,Ferraro Giarita¹,Cipollone Irene¹²,Garribba Eugenio³^ORCID,Monti Maria¹²,Merlino Antonello¹^ORCID

Affiliation:

1. Department of Chemical Sciences, University of Naples Federico II, Complesso Universitario di Monte Sant'Angelo, Via Cintia, I-80126, Napoli, Italy

2. CEINGE Biotecnologie Avanzate ‘Franco Salvatore’, Via G. Salvatore, 486, 80131, Napoli

3. Dipartimento di Medicina, Chirurgia e Farmacia, Università di Sassari, Viale San Pietro, I-07100 Sassari, Italy

Abstract

The structure of the adduct formed by lysozyme with bis(maltolato)oxovanadium(iv) within crystals grown in NaCl and Na-acetate at pH 4.0 reveals an unexpected reaction product.

Funder

Ministero dell’Istruzione, dell’Università e della Ricerca

Fondazione di Sardegna

Publisher

Royal Society of Chemistry (RSC)

Link

http://pubs.rsc.org/en/content/articlepdf/2024/QI/D4QI01528B

Reference66 articles.

1. ESI-MS Study of the Interaction of Potential Oxidovanadium(IV) Drugs and Amavadin with Model Proteins

2. In vitro and in vivo antitumor effects of the VO-chrysin complex on a new three-dimensional osteosarcoma spheroids model and a xenograft tumor in mice

3. New VIV, VIVO, VVO, and VVO2 Systems: Exploring their Interconversion in Solution, Protein Interactions, and Cytotoxicity

4. Vanadium compounds in medicine

5. The chemistry and biology of vanadium compounds in cancer therapeutics